Skip to main content
Fig. 7 | Military Medical Research

Fig. 7

From: Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy

Fig. 7

Flow cytometry-based immunoprofiling and quantification of immune cells in tumors. Cells infiltrating the tumors, representing percentage of CD3+ cells (a), CD3+CD8+OVA-TCR+ cells (b), CD4:CD8 ratio (c), F4/80+CD206+ M2 macrophages (d), F4/80+CD80+ M1 macrophages (e), CD11c+ dendritic cells (f), CD14+ monocytes (g), and CD19+ B-cells (h). *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA with Tukey’s test. OVA ovalbumin, TCR T-cell receptor, BLV bolus lentiviruses, SLV scaffold loaded lentiviruses

Back to article page